Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) was the recipient of some unusual options trading activity on Friday. Stock investors purchased 2,543 call options on the stock. This represents an increase of 337% compared to the average volume of 582 call options.
Analyst Ratings Changes
A number of research firms have recently commented on COSM. Noble Financial initiated coverage on shares of Cosmos Health in a research note on Monday, October 26th. They set an “outperform” rating for the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday, October 28th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.
Cosmos Health Trading Up 4.9%
Shares of Cosmos Health stock traded up $0.01 on Friday, hitting $0.30. The stock had a trading volume of 197,308 shares, compared to its average volume of 4,100,915. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.92 and a current ratio of 1.05. Cosmos Health has a twelve month low of $0.16 and a twelve month high of $0.82. The firm has a market capitalization of $30.59 million, a P/E ratio of -0.47 and a beta of 4.73. The stock has a 50 day moving average of $0.31 and a 200 day moving average of $0.31.
Cosmos Health (NASDAQ:COSM – Get Free Report) last issued its quarterly earnings results on Tuesday, August 18th. The company reported ($0.10) earnings per share for the quarter, meeting the consensus estimate of ($0.10). Cosmos Health had a negative return on equity of 56.88% and a negative net margin of 33.08%. The company had revenue of $19.32 million during the quarter, compared to analysts’ expectations of $18.99 million. Sell-side analysts expect that Cosmos Health will post -0.15 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Cosmos Health
An institutional investor recently bought a new position in Cosmos Health stock. BlackRock Inc. bought a new stake in shares of Cosmos Health Inc. (NASDAQ:COSM – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 267,797 shares of the company’s stock, valued at approximately $49,000. BlackRock Inc. owned about 0.45% of Cosmos Health as of its most recent SEC filing. 12.61% of the stock is currently owned by institutional investors and hedge funds.
About Cosmos Health
Cosmos Health Inc is a healthcare group that develops, manufactures and distributes pharmaceutical, nutraceutical and healthcare products. Its portfolio includes branded dietary supplements, vitamins and wellness products, as well as pharmaceutical products and medical devices distributed through retail, wholesale and online channels.
The company markets its nutraceutical products under the Sky Premium Life brand, which offers supplements and other health and wellness products. Cosmos Health also has manufacturing and product-development activities through Cana Laboratories, a Greece-based pharmaceutical manufacturer that produces pharmaceutical and healthcare products for its own portfolio and third parties.
Founded in 2009 and formerly known as Cosmos Holdings, the company adopted the Cosmos Health name in 2022.
See Also
- Five stocks we like better than Cosmos Health
- Arista Networks Cashes In on the AI Infrastructure Buildout
- Powering Up: Freeport-McMoRan’s $4.5B Copper Expansion
- 3 Dividend ETFs Offer Different Ways to Navigate the Post-Election Sell-Off
- Riot’s $28B Lease Shows Why Location and Contracts Matter in AI
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.
